Accession Number: | 0001104659-21-141628 |
Date: | 2021-11-17 |
Issuer: | INHIBIKASE THERAPEUTICS, INC. (IKT) |
Original Submission Date: |
WERNER MILTON H.
3350 RIVERWOOD PARKWAY SE, SUITE 1900
ATLANTA, GA 30339
Title of Security | Transaction Date | 2a. Deemed Execution Date | Transaction Code | Shares | Acquired or Disposed | Price per share | 5. Amount of Securities Beneficially Owned Following Reported Transaction | 6. Ownership Form Direct or Indirect | Nature of Indirect Ownership |
---|---|---|---|---|---|---|---|---|---|
COMMON STOCK | 2021-11-17 | P | 17,569 | a | $1.98 | 23,589 | indirect | ||
COMMON STOCK | 2021-11-17 | P | 1,100 | a | $1.97 | 23,589 | indirect | ||
COMMON STOCK | 2021-11-17 | P | 3,186 | a | $1.96 | 23,589 | indirect | ||
COMMON STOCK | 2021-11-17 | P | 1,334 | a | $1.94 | 23,589 | indirect | ||
COMMON STOCK | 2021-11-17 | P | 400 | a | $1.93 | 23,589 | indirect | ||
COMMON STOCK | 2021-11-17 | 0 | $0.00 | 5,293,580 | direct |
Title of Derivative Security | Conversion or Exercise Price of Derivative Security | Transaction Date | Deemed Execution Date | Transaction Code | Number of Derivative Securities Acquired (A) or Disposed of (D) | Date Exercisable | Expiration Date | Title and Amount of Securities Underlying Derivative Security | Price of Derivative Security | Number of derivative Securities Beneficially Owned Following Reported Transaction(s) | Ownership Form: Direct (D) or Indirect (I) | Nature of Indirect Beneficial Ownership |
---|
ID | footnote |
---|---|
f1 | the reporting person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the reporting person is the beneficial owner of such securities for purposes of section 16 or for any other purpose. |